Please login to the form below

Not currently logged in
Email:
Password:

Former Opinion Matters founder launches new agency

Yolo Communications aims to build on social media strategies

Nik Harta Yolo CommsFormer markettiers4dc director, Nik Harta has launched his own full-service research and marketing agency called Yolo Communications. 

Focusing on research for PR and media, the agency has developed a new service to produce 'Research through Social Media' to create actionable insights through unique analysis of social media monitoring and listening.

Yolo Communications' Research through Social Media service embraces the opportunity social media has to offer by using the depth of opinions and content available to help clients interpret, understand and engage with their audiences. 

The firm's service enables clients to learn what their customers are talking about while also allowing them to discover the context of conversations and the language used to proactively participate, lead and influence conversations.

After starting and developing markettiers4dc's research division Opinion Matters more than a decade ago, Harta has worked on numerous award-winning campaigns for the likes of GSK, Merck, UCB, Astellas, Bayer, Biogen Idec, and Abbott Nutrition. 

Commenting on the launch, Harta (pictured) says: “While we continue to provide a cost-effective, creative and consultative approach to our core research here at Yolo Communications, we also want to use technology to benefit our clients and are delighted to announce our Research through Social Media service. 

“I enjoy working across the pharma and healthcare sector and have been fortunate enough to provide research support for great PR and brand teams and now we are really excited about the positive response we have had from those clients since the launch of Yolo Communications.”

“We are pleased to have already gained some notable international successes for our new service, producing strategic insights for Healthcare clients, and our team is enthused about the potential we can deliver.”


Article by
Ben Adams

18th June 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics